Search

Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.

… Monday, April 3, 2017 Summary For patients with leukemia who relapse after chemotherapy, treatment options have traditionally been limited. At MSK, an experimental immunotherapy called CAR T therapy has expanded options for these patients. New research data presented at this year’s annual meeting of

Evidence from a recent study, led by MSK urologic surgeon, Behfar Ehdaie, MD, MPH, indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later treatment is required.

… Friday, October 25, 2024 Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later treatment is required. For the past five years, a team of MSK researchers has

Nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center in August 2010. He also becomes President of Gerstner Sloan Kettering Graduate School of Biomedical Sciences.

… Wednesday, December 15, 2010 In August 2010, nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center. He succeeded Harold Varmus, now Director of the National Cancer Institute. Dr. Thompson also

Cancer doesn’t stop for a pandemic, but as local governments around the nation mandated the stoppage of elective surgery, Memorial Sloan Kettering Cancer Center (MSK) surgeons had to consider several critical questions.

… Tuesday, May 12, 2020 Cancer doesn’t stop for a pandemic, but as local governments around the nation mandated the stoppage of elective surgery, Memorial Sloan Kettering Cancer Center (MSK) surgeons had to consider several critical questions: What is elective cancer surgery, and what is essential cancer

Total gastrectomy is indicated for patients with stomach cancer gene mutations regardless of family history.

… Monday, November 9, 2020 Risk-reducing prophylactic total gastrectomy may be warranted for patients with pathogenic or likely pathogenic CDH1 variants and a family history of gastric cancer or lobular breast cancer. Moreover, it should be considered for patients with CDH1 variants who do not have a family

For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan Kettering Cancer Center, St. Jude Children’s Research Hospital, University of Washington, and other institutions.

… Sunday, September 8, 2013 For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan Kettering Cancer Center, St. Jude Children’s Research Hospital, University of Washington, and other institutions. The discovery

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, August 17, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named Founding Member of New York Jobs CEO Council Craig B. Thompson Craig B. Thompson, MD , President and Chief Executive Officer (CEO) of MSK, was named a founding

Lopez was recognized for his positive impact on New York City through his professional, communal, and philanthropic achievements.

… Tuesday, September 20, 2022 Jorge Lopez, Jr. , Executive Vice President (EVP) and General Counsel at Memorial Sloan Kettering Cancer Center (MSK), was recognized as a Notable Hispanic Leader and Executive in today’s Crain’s New York Business special editorial feature . This piece spotlights exceptional

Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer.

… Wednesday, April 25, 2018 At Memorial Sloan Kettering, social workers hope people cope with the logistical and emotional difficulties of cancer. Learn how Penny Damaskos, Director of Social Work at MSK, came into the field and what she’s learned about resilience along the way. She was recently awarded

A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.

… Wednesday, January 19, 2022 Cancer treatment using chimeric antigen receptor (CAR) T cells has gained acclaim, thanks to striking success  in treating people with several types of advanced blood cancers such as leukemia . The approach, which was pioneered at Memorial Sloan Kettering Cancer Center, involves